Investment ThemesDetailed Quotes
CAR-T Therapy
Watchlist
- 1022.763
- +6.280+0.62%
Close Nov 27 16:00 ET
1026.812High1017.638Low
1017.638Open1016.483Pre Close57.37MVolume9Rise15.98P/E (Static)4.04BTurnover--Flatline0.40%Turnover Ratio1.08TMarket Cap1Fall1.07TFloat Cap
Constituent Stocks: 10Top Rising: ADAP+6.62%
Sign in to post a comment
$bluebird bio (BLUE.US)$ FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)
Benzinga· 23 mins ago
WARNING: HEMATOLOGIC MALIGNANCY Hematologic malignancy, including life-threatening cases of myelodysplastic syndrome, has occurred in patients treated with SKYSONA. Patients have been diagnosed between 14 months and 7.5 years after SKYSONA administ...
Benzinga· 23 mins ago
WARNING: HEMATOLOGIC MALIGNANCY Hematologic malignancy, including life-threatening cases of myelodysplastic syndrome, has occurred in patients treated with SKYSONA. Patients have been diagnosed between 14 months and 7.5 years after SKYSONA administ...
1
18
Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
+1
1
Columns Returns since election...
Dogecoin: +125%
MicroStrategy: +55% $MicroStrategy (MSTR.US)$
Coinbase: +51% Tesla: +35% $Coinbase (COIN.US)$
Bitcoin: +32% Banks: +14% $Bitcoin (BTC.CC)$
Small Caps: +7.3% $iShares Russell 2000 ETF (IWM.US)$
S&P 500: +4.2% $S&P 500 Index (.SPX.US)$
US Dollar: +3.7% $USD (USDindex.FX)$
US Bonds: +0.2%
---
International Stocks: -3.1%
Oil: -4.2%
Gold: -4.2%
Pfizer: -6.8% $Pfizer (PFE.US)$
China: -9.6%
Trump Media: -10% $Trump Media & Technology (DJT.US)$
Moderna: -21% $Moderna (MRNA.US)$
...
MicroStrategy: +55% $MicroStrategy (MSTR.US)$
Coinbase: +51% Tesla: +35% $Coinbase (COIN.US)$
Bitcoin: +32% Banks: +14% $Bitcoin (BTC.CC)$
Small Caps: +7.3% $iShares Russell 2000 ETF (IWM.US)$
S&P 500: +4.2% $S&P 500 Index (.SPX.US)$
US Dollar: +3.7% $USD (USDindex.FX)$
US Bonds: +0.2%
---
International Stocks: -3.1%
Oil: -4.2%
Gold: -4.2%
Pfizer: -6.8% $Pfizer (PFE.US)$
China: -9.6%
Trump Media: -10% $Trump Media & Technology (DJT.US)$
Moderna: -21% $Moderna (MRNA.US)$
...
5
3
$Pfizer (PFE.US)$ interesting, i dont think this goes under 25.60 as much as i'd like to see it tank.. something is brewing for breakout
1
3
The market again hit records Tuesday, reacting mostly positively toward incoming President-Elect Trump's comments overnight that he would put a 25% tariff on our neighbors in Canada and Mexico and 35% on Chinese goods, our three largest trading partners.
According to Census Bureau data, there are price hikes in the goods on 41% of the U.S.'s total imports; there has been $1.6T trade so far in 2024. A blanket ...
According to Census Bureau data, there are price hikes in the goods on 41% of the U.S.'s total imports; there has been $1.6T trade so far in 2024. A blanket ...
31
9
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Amgen (AMGN.US)$ A 20% weight loss reduction in one year is fantastic and healthy from a medical standpoint. A 5 foot 4 inches woman at 180 pounds would loss guaranteed 36 pounds over 1 year be down to a much healthier 144 pounds. This is impressive results. I don’t understand the selloff. The human body should lose weight in a healthy fashion. I don’t know what you guys are expecting . This is great news .
5
1
1
$Amgen (AMGN.US)$ feels overdone for decent Phase 2 data.
1
Good morning, traders. Happy Tuesday, November 26th. The Dow closed at a high yesterday, and the S&P 500 hit a trading record.
You will not make it through today without the news and animal spirits moving markets. My name is Kevin Travers, here is what's live:
$Amgen (AMGN.US)$ investors tightened their belts and shaved 11% of the stock price Tuesday after the firm said in a press release their Phase 2 study of MariTide showed ...
You will not make it through today without the news and animal spirits moving markets. My name is Kevin Travers, here is what's live:
$Amgen (AMGN.US)$ investors tightened their belts and shaved 11% of the stock price Tuesday after the firm said in a press release their Phase 2 study of MariTide showed ...
32
25
$Amgen (AMGN.US)$ whats going on???
2
No comment yet
Jaguar8 : That is the really the accompanying risk of being ina clinical trial. This kind of adverse events is just troubling. I wonder how high their attrition rate is
Trytosaveabit OP Jaguar8 : Yeah I know! It just sux! You have a drug that really helps just to find out later it can add to the already bad situation! Grrr
Jaguar8 Trytosaveabit OP : True. Some subjects even die
Trytosaveabit OP Jaguar8 : Yup! My Mom was in a trial!
Jaguar8 Trytosaveabit OP : and what happened?
View more comments...